4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000180
Chairperson & CEO sold 1,723 shares at an average $611.06 ($1,052,854)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-04 | Sale : show line 1 in the form 10b5-1 | −842 | $610.29 | $513,867 | 325,324 | I |
| 2026-11-04 | Sale : show line 2 in the form 10b5-1 | −403 | $611.26 | $246,337 | 324,921 | I |
| 2026-11-04 | Sale : show line 3 in the form 10b5-1 | −398 | $612.06 | $243,600 | 324,523 | I |
| 2026-11-04 | Sale : show line 4 in the form 10b5-1 | −80 | $613.14 | $49,051 | 324,443 | I |
| Open-market sales · 1,723 sh · avg $611.06 · $1,052,854 | ||||||
Loading xslF345X06/primarydocument.xml…